You just read:

Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma

News provided by

Innovent Biologics, Inc.

Oct 20, 2019, 20:00 ET